Nu-Med Plus NUMD
OTC NUMD
$0.02 +0.00 (+0.00%)
At close: Aug 17, 2026 · 4:00 PM UTC

Nu-Med Plus (NUMD) Cash from Investing Activities (2012 - 2022)

Nu-Med Plus (NUMD) posted Cash from Investing Activities of $3000.0 for Q1 2022, up 299900.0% sequentially from $1.0 in Q4 2018.

Nu-Med Plus (NUMD) Cash from Investing Activities (2012 - 2022) Analysis & Trends

Nu-Med Plus has reported Cash from Investing Activities for 5 years, with the latest figure at $3000.0 in Q1 2022.

  • Quarterly Cash from Investing Activities changed N/A year-over-year to $3000.0 in Q1 2022, while the trailing twelve-month figure through Sep 2022 was $3000.0 (changed N/A YoY) and the FY2018 annual result came in at -$5025.0, changed N/A from the prior year.
  • Cash from Investing Activities grew to $3000.0 in Q1 2022 per NUMD's latest filing, from $1.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $3000.0 in Q1 2022 and troughed at -$5026.0 in Q2 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 199.45 Bn 193.85 Bn 7.27 Bn -673.00 Mn
2 Stryker 127.62 Bn 124.14 Bn 4.50 Bn -639.00 Mn
3 Medtronic 118.98 Bn 109.76 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 73.41 Bn 72.87 Bn 3.85 Bn -1.96 Bn
5 Edwards Lifesciences 51.89 Bn 47.64 Bn 1.35 Bn -193.20 Mn
6 Dexcom 34.33 Bn 32.38 Bn 830.00 Mn 329.80 Mn
7 GE HealthCare Technologies 33.87 Bn 31.76 Bn 2.18 Bn -115.00 Mn
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn -22.08 Mn
9 Steris 23.04 Bn 22.56 Bn 684.20 Mn -108.50 Mn
10 Nu-Med Plus 2.03 Mn 2.02 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2022 3,000.00
Mar 31, 2022 3,000.00
Dec 31, 2018 1.00
Dec 31, 2018 1.00
Jun 30, 2018 -5,026.00
Jun 30, 2018 -5,026.00
Dec 31, 2014 -1,101.00
Dec 31, 2014 -1,101.00
Sep 30, 2013 -1,679.00
Sep 30, 2013 -1,679.00
Dec 31, 2012 -19,354.00
Dec 31, 2012 -19,354.00
Sep 30, 2012 -1.00
Sep 30, 2012 -1.00
Jun 30, 2012 -18,835.00
Jun 30, 2012 -18,835.00